<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02232737</url>
  </required_header>
  <id_info>
    <org_study_id>P50DA036114:P3S2</org_study_id>
    <secondary_id>P50DA036114</secondary_id>
    <nct_id>NCT02232737</nct_id>
  </id_info>
  <brief_title>Project 3, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in People With Current Affective Disorders</brief_title>
  <official_title>Project 3, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in People With Current Affective Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Vermont</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Brown University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine extended exposure to cigarettes varying in nicotine content among&#xD;
      people with affective disorders. People with affective disorders are at an increased risk for&#xD;
      smoking, nicotine dependence, and using high nicotine yield cigarettes and are also at&#xD;
      significantly increased risk for smoking-related adverse health consequences. Studies testing&#xD;
      an innovative regulatory strategy of reducing the nicotine content of cigarettes to a&#xD;
      non-addictive level have shown promising beneficial effects (decreased smoking rate, reduced&#xD;
      toxicant exposure, and increased cessation) in the general population of smokers. However,&#xD;
      these studies have uniformly excluded vulnerable populations like people with current&#xD;
      affective disorders, who may respond differently considering their greater vulnerability to&#xD;
      smoking and nicotine dependence. Thus, little is known scientifically about how this highly&#xD;
      vulnerable subgroup of smokers may respond to a nicotine reduction policy. This project is&#xD;
      designed to fill that substantial knowledge gap.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 7, 2016</start_date>
  <completion_date type="Actual">January 14, 2019</completion_date>
  <primary_completion_date type="Actual">January 14, 2019</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cigarettes per day</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">270</enrollment>
  <condition>Tobacco Use Disorder</condition>
  <arm_group>
    <arm_group_label>0.8 mg nicotine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.8 mg nicotine cigarettes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.12 mg nicotine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.12 mg nicotine cigarettes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.03 mg nicotine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.03 mg nicotine cigarettes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Very low nicotine content cigarettes</intervention_name>
    <arm_group_label>0.03 mg nicotine</arm_group_label>
    <arm_group_label>0.12 mg nicotine</arm_group_label>
    <arm_group_label>0.8 mg nicotine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or Female&#xD;
&#xD;
          -  Ages 18-70&#xD;
&#xD;
          -  Past-year major depressive disorder, dysthymic disorder, generalized anxiety disorder,&#xD;
             post-traumatic stress disorder, obsessive-compulsive disorder, phobia, or panic&#xD;
             disorder with or without agoraphobia, based on MINI structured interview, OR lifetime&#xD;
             diagnosis of one of the above based on MINI with a self-report of currently receiving&#xD;
             treatment (prescribed psychoactive medication, behavioral therapy, etc.)&#xD;
&#xD;
          -  Report smoking 5 or more cigarettes per day for the past year&#xD;
&#xD;
          -  Provide an intake breath CO sample &gt; 8 ppm&#xD;
&#xD;
          -  Be without current substance abuse/dependence other than nicotine&#xD;
&#xD;
          -  Be sufficiently literate to complete the research-related tasks&#xD;
&#xD;
          -  Be in good physical health without serious illness or change in health in the past 3&#xD;
             months as determined by the licensed medical professional at each site&#xD;
&#xD;
          -  Not pregnant or nursing and report using oral, implant, patch, ring, IUD, injection or&#xD;
             barrier contraceptives or report being surgically sterile or post-menopausal&#xD;
&#xD;
          -  Report no significant use of other tobacco or nicotine products within the past month&#xD;
             (&gt; 9 days in the past 30)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any prior regular use (used as primary cigarette outside of the laboratory) of&#xD;
             Spectrum cigarettes (i.e., research cigarettes with reduced nicotine content)&#xD;
&#xD;
          -  Exclusive use of roll-your-own cigarettes&#xD;
&#xD;
          -  Planning to quit smoking in the next 30 days&#xD;
&#xD;
          -  A quit attempt in the past 30 days resulting in &gt; 3 days of abstinence&#xD;
&#xD;
          -  Positive toxicology screen for illicit drugs not including marijuana (participants&#xD;
             with valid prescriptions will not be excluded and participants with a positive&#xD;
             toxicology screen will be allowed to re-screen once)&#xD;
&#xD;
          -  Breath alcohol level &gt; 0.01 (participants with a positive screen will be allowed to&#xD;
             re-screen once)&#xD;
&#xD;
          -  Self-report of binge drinking alcohol (&gt; 9 days in the past 30, 4/5 drinks in 2 hours&#xD;
             for women/men&#xD;
&#xD;
          -  Systolic blood pressure below 90 mmHg or greater than or equal to 160 mmHg&#xD;
             (participants outside the range will be allowed to re-screen once)&#xD;
&#xD;
          -  Diastolic blood pressure below 50 mmHg or greater than or equal to 100 mmHg&#xD;
             (participants outside the range will be allowed to re-screen once)&#xD;
&#xD;
          -  Breath CO &gt; 80 ppm&#xD;
&#xD;
          -  Heart rate below 45 or greater than or equal to 115 bpm (participants outside the&#xD;
             range will be allowed to re-screen once)&#xD;
&#xD;
          -  Currently seeking treatment for smoking cessation&#xD;
&#xD;
          -  Have used nicotine replacement, bupropion or other pharmacotherapies as cessation aids&#xD;
             in the past month (bupropion for treatment of depression will be allowed)&#xD;
&#xD;
          -  Unstable psychiatric conditions (psychiatric medication changes in the past 4 weeks)&#xD;
&#xD;
          -  Current symptoms of psychosis, dementia or mania&#xD;
&#xD;
          -  Suicidal ideation in past month&#xD;
&#xD;
          -  Suicide attempt in past 6 months&#xD;
&#xD;
          -  Participation in another research study in the past 30 days&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen T Higgins, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Vermont</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Brown University</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Vermont</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>September 3, 2014</study_first_submitted>
  <study_first_submitted_qc>September 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2014</study_first_posted>
  <last_update_submitted>June 8, 2020</last_update_submitted>
  <last_update_submitted_qc>June 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brown University</investigator_affiliation>
    <investigator_full_name>Jennifer Tidey</investigator_full_name>
    <investigator_title>Professor (Research)</investigator_title>
  </responsible_party>
  <keyword>Biomarkers of exposure</keyword>
  <keyword>Compensatory smoking</keyword>
  <keyword>Nicotine dependence</keyword>
  <keyword>Reduced nicotine cigarettes</keyword>
  <keyword>Tobacco withdrawal</keyword>
  <keyword>Women</keyword>
  <keyword>Health disparaties</keyword>
  <keyword>Vulnerable populations</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
    <mesh_term>Mood Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

